Cargando…

Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve – an observational study

BACKGROUND: To assess and compare the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve. METHODS: Prospective, observational, open-label study performed at the 3rd Chair and Department of Gynecology of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czuczwar, Piotr, Stepniak, Anna, Milart, Pawel, Paszkowski, Tomasz, Wozniak, Slawomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984745/ https://www.ncbi.nlm.nih.gov/pubmed/29859107 http://dx.doi.org/10.1186/s13048-018-0420-1

Ejemplares similares

Ulipristal acetate as a treatment option for uterine fibroids
por: Piecak, Karolina, et al.
Publicado: (2017)

The effect of ulipristal acetate treatment on symptomatic uterine fibroids within 12-months follow-up
por: Woźniak, Sławomir, et al.
Publicado: (2014)

The influence of uterine artery embolisation on ovarian reserve, fertility, and pregnancy outcomes – a review of literature
por: Czuczwar, Piotr, et al.
Publicado: (2017)

Predicting the results of uterine artery embolization: correlation between initial intramural fibroid volume and percentage volume decrease
por: Czuczwar, Piotr, et al.
Publicado: (2014)

Successful Pregnancy after Treatment with Ulipristal Acetate for Uterine Fibroids
por: Monleón, Javier, et al.
Publicado: (2014)

Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids
por: Biglia, Nicoletta, et al.
Publicado: (2014)

Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence
por: Trefoux Bourdet, Alice, et al.
Publicado: (2015)

Safety after extended repeated use of ulipristal acetate for uterine fibroids
por: Fauser, Bart C. J. M., et al.
Publicado: (2017)

Economic impact of ulipristal acetate on surgical procedures for uterine fibroids in France
por: Fernandez, Hervé, et al.
Publicado: (2017)

Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids
por: Middelkoop, Mei-An, et al.
Publicado: (2022)

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate
por: Kolterud, Åsa, et al.
Publicado: (2022)

Ulipristal Acetate Efficacy in a Patient with Symptomatic Fibroid and Concomitant Pulmonary Embolism
por: von Wunster, S., et al.
Publicado: (2020)

Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis
por: Geale, Kirk, et al.
Publicado: (2017)

Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
por: Ekanem, Emmanuel, et al.
Publicado: (2020)

Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate
por: Rabe, Thomas, et al.
Publicado: (2018)

Is ulipristal acetate the new drug of choice for the medical management of uterine fibroids? Res ipsa loquitur?
por: Odejinmi, Funlayo, et al.
Publicado: (2017)

The use of a short course of Ulipristal Acetate for acute abnormal uterine bleeding in women without uterine fibroids
por: Lambrecht, I, et al.
Publicado: (2023)

Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
por: Rabe, Thomas, et al.
Publicado: (2018)

Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2020)

Markers of Inflammation and Vascular Parameters in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2021)

Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management
por: Tsoi, Bernice, et al.
Publicado: (2015)

Phase III long‐term study to evaluate the efficacy and safety of ulipristal acetate in Japanese patients with uterine fibroids
por: Osuga, Yutaka, et al.
Publicado: (2021)

Safety and efficacy of two repeated cycles of ulipristal acetate in the management of symptomatic uterine fibroid among Indian women
por: Jha, Sangam, et al.
Publicado: (2021)

Fertility impairment associated with uterine fibroids – a review of literature
por: Lisiecki, Marek, et al.
Publicado: (2017)

Ulipristal acetate before in vitro fertilization: efficacy in infertile women with submucous fibroids
por: Morgante, Giuseppe, et al.
Publicado: (2020)

Supracervical hysterectomy – the vaginal route
por: Wilczyński, Miłosz, et al.
Publicado: (2014)

Elastography in predicting preterm delivery in asymptomatic, low-risk women: a prospective observational study
por: Wozniak, Slawomir, et al.
Publicado: (2014)

Comparison of outcomes of laparoscopic sacrocolpopexy with concomitant supracervical hysterectomy or uterine preservation
por: Sato, Hirotaka, et al.
Publicado: (2023)

Laparoscopic Supracervical Hysterectomy Compared to Total Hysterectomy
por: Cipullo, Lucio, et al.
Publicado: (2009)

Ulipristal acetate for Japanese women with symptomatic uterine fibroids: A double‐blind, randomized, phase II dose‐finding study
por: Irahara, Minoru, et al.
Publicado: (2019)

Ulipristal Acetate in Adenomyosis
por: Gonçalves-Henriques, Manuel, et al.
Publicado: (2022)

Uterine artery embolization in the treatment of symptomatic fibroids – state of the art 2018
por: Stępniak, Anna
Publicado: (2018)

Comparative study of supracervical hysterectomy between da Vinci SP(®) surgical system and conventional single-site laparoscopy for uterine fibroid: single center experiences
por: Lee, Juhun, et al.
Publicado: (2023)

Expulsion of a uterine myoma in a patient treated with ulipristal acetate
por: Chantraine, Frederic, et al.
Publicado: (2015)

Successful Laparoscopic-Assisted Supracervical Hysterectomy in a 14-Week-Sized Fibroid Uterus: An Autobiographical Case Report
por: Eburne, Leah, et al.
Publicado: (2022)

Total surgical time in laparoscopic supracervical hysterectomy with laparoscopic in-bag-morcellation compared to laparoscopic supracervical hysterectomy with uncontained morcellation
por: Krentel, H, et al.
Publicado: (2022)

Laparoscopic Supracervical Hysterectomy versus Laparoscopic-Assisted Vaginal Hysterectomy
por: Song, Xue, et al.
Publicado: (2011)

Suspension of ulipristal acetate for uterine fibroids during ongoing EMA’s review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!
por: Rozenberg, Serge, et al.
Publicado: (2020)

Markers of Cellular Proliferation, Apoptosis, Estrogen/Progesterone Receptor Expression and Fibrosis in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2021)

3D Power Doppler vascular indices as a novel technique in assessing the outcome of minimally invasive techniques in uterine fibroids treatment
por: Stępniak, Anna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6vggdpulank7h4rou6c59s1gto